Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · refreshes every 15s during session
Limited proprietary earnings coverage for SANA yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 15d ago
SANA's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on SANA.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Sana Biotechnology, Inc. (SANA) — events, not interpretation.
Research & analysis only — not investment advice.
Held in ETFsweight · est. sleeve dollars
AlphaOS industries
Investment snapshot
SANA's AI investment thesis
Upgrade to Premium for SANA's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Latest price
$2.95
Market cap
$881.62M
Profitable
—
Net income
—
FY Sep 21, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Sana Biotechnology, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Sana Biotechnology, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.